Health
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world's first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX e...
2026-08-08 15:46
1544
NutriPQQ® Publishes New PQQ Sourcing Guide for Supplement Brands and Manufacturers
The new B2B resource helps procurement, formulation, and quality teams evaluate PQQ production methods, ingredient identity, testing, stability, packaging, and supply continuity. Key Highlights * Provides a practical framework for comparing PQQ suppliers beyond quoted price and assay percenta...
2026-08-07 23:00
583
Alebund's AP301 NDA Accepted for Review by China's NMPA
SHANGHAI, Aug. 7, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the New Drug Application (NDA) for AP301 capsules, a novel oral iron-based phosphate binder, for the treatmen...
2026-08-07 18:40
1142
Check out Hainan's Pioneering Medical Hub
Uncover the New Charms of Boao Lecheng Medical Tourism HAIKOU, China, Aug. 7, 2026 /PRNewswire/ -- A news report from PDDC: Coastal scenery soothes body and mind, while cutting‑edge medical services empower health‑and‑wellness tourism. Bolstered by the opening‑up dividends of Hainan Free Trade P...
2026-08-07 18:27
1248
CityUHK ranked No.1 in Hong Kong in Nature Index 2026 Nanoscience and Nanotechnology Supplement
HONG KONG, Aug. 7, 2026 /PRNewswire/ -- City University of Hong Kong (CityUHK)
has achieved another significant milestone in global research excellence.
Following its earlier achievement of ranking 38th globally and 1st in Hong Kong
in the"Nature Index 2026 Chemistry Supplement"
2026-08-07 17:58
1189
Beyond Encouragement: Momcozy Calls for Breastfeeding Support That Works in Real Life
SYDNEY, Aug. 7, 2026 /PRNewswire/ -- This
2026-08-07 17:47
1092
STARCARES Revamps Basketball Court at the University of Lagos for Future Healthcare Professionals
The revitalised basketball court gives approximately 2,000 future healthcare professionals a dedicated space to recharge, connect, and build community activities beyond their academic training LAGOS, Nigeria, Aug. 7, 2026 /PRNewswire/ -- STARCARES, the community impact initiative of STARTRADER, ...
2026-08-07 16:45
1262
STARCARES Revamps Basketball Court at the University of Lagos for Future Healthcare Professionals
The revitalised basketball court gives approximately 2,000 future healthcare professionals a dedicated space to recharge, connect, and build community activities beyond their academic training LAGOS, Nigeria, Aug. 7, 2026 /PRNewswire/ -- STARCARES, the community impact initiative of STARTRADER, ...
2026-08-07 16:30
1062
Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China
NANJING, China and GAITHERSBURG, Md., Aug. 7, 2026 /PRNewswire/ -- TransThera Sciences' Yochanra® is the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma. On 6 August 2026,...
2026-08-07 14:44
1259
CLASSYS Appoints Former Samsung Electronics and Vuno Executive Dr. Taek-Soo Kim as Chief Technology Officer, Accelerating Its Evolution into a Global Medical Aesthetics Technology Company
SEOUL, South Korea, Aug. 7, 2026 /PRNewswire/ -- CLASSYS (KOSDAQ: 214150), a global medical aesthetics platform company, announced the appointment of Dr. Taek-Soo Kim, a distinguished technology management expert, as its new Chief Technology Officer (CTO) and Head of Research and Development. ...
2026-08-07 08:16
2438
Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS
NANTONG, China, Aug. 6, 2026 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics, today announced the completion of patient enrollment and initial dosing across all cohorts in its Phase II clinical trial evaluating RAG-17, an ...
2026-08-06 19:30
561
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of $17.00 per sha...
2026-08-06 18:46
1008
Harbour BioMed Appoints Dr. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment ...
2026-08-06 16:10
782
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
Expanded capabilities across Cortellis portfolio help life sciences
organizations turn trusted intelligence into action and accelerate decision
making across the research and development lifecycle
LONDON, Aug. 6, 2026 /PRNewswire/ -- Clarivate Plc
2026-08-06 16:00
738
Chugai Pharma Taiwan (CPT) Secures Dual Recognition at the Asia Responsible Enterprise Awards (AREA) for Health Promotion and Green Leadership Initiatives
SINGAPORE, Aug. 6, 2026 /PRNewswire/ -- Chugai Pharma Taiwan (CPT) was recognized at the Asia Responsible Enterprise Awards (AREA) 2026organised by Enterprise Asia under the Health Promotion and Green Leadership categories for its integrated ESG approach that advances human health, employee well-...
2026-08-06 15:11
1370
Fosun International Wins Three Awards from Global Banking & Finance Review, Gaining International Recognition for its ESG Performance, Corporate Social Responsibility, and Brand Strength
HONG KONG, Aug. 6, 2026 /PRNewswire/ -- Recently, Global Banking and Finance Review, a leading British financial magazine, announced its 2026 award winners. Fosun International Limited (HKEX stock code: 00656) received three awards in recognition of its outstanding contributions to sustainable de...
2026-08-06 13:17
2164
Herbalgy Trophy Ignites Hong Kong as Football Fever Sweeps the City
Juventus Defeat Chelsea FC 1–0 "Goal-Getter Giveaway" Opens the Door to World-Class Football1, While 5 Children Fulfil Their Dreams as Player Mascots HONG KONG, Aug. 6, 2026 /PRNewswire/ -- The Herbalgy Trophy: Chelsea FC vs Juventus, the headline of the Hong Kong Football Festival 2026 proudly ...
2026-08-06 10:46
1570
SYNTEC Group Recognized for Employee Health and Community Well-Being at Asia Responsible Enterprise Awards 2026
KUALA LUMPUR, Malaysia, Aug. 6, 2026 /PRNewswire/ -- SYNTEC Group has been recognized at the Asia Responsible Enterprise Awards (AREA) 2026, organized by Enterprise Asia, under the Health Promotion category for its "Employee Health Support System", which promotes employee well-being, psychologica...
2026-08-06 09:00
2576
From Patient to Storyteller: Dale Returns to Shanghai After CAR-T Recovery, Sharing a Journey of Hope
SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- After overcoming stage 4B lymphoma through CAR-T therapy, New Zealand patient Dale has returned to Shanghai—not as a patient seeking treatment, but as a survivor sharing his story. Recently, Dale came back to the city where he received life-changing care, to...
2026-08-06 08:57
1765
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China
SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2026-08-06 08:00
2115
Week's Top Stories
Most Reposted
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
[Picked up by 325 media titles]
2026-08-05 11:34
MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 307 media titles]
2026-08-07 22:30Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 296 media titles]
2026-08-06 15:10
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 296 media titles]
2026-08-04 07:00
Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
[Picked up by 292 media titles]
2026-08-04 14:30
Most Read
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
2026-08-04 07:00
10449
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
2026-08-05 11:34
8105
Singapore Good Soil Foundation Hosts Third Next Generation Philanthropy Leadership Program at the University of Hong Kong, Empowering the Next Generation of Global Changemakers
2026-08-02 02:09
7569
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
2026-08-04 06:00
6943
Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
2026-08-04 14:30
6619